Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Hot Topics in Investor Activism: Yale University Conference for Corporate Responsibility

On 13 April, Thomas Collin-Lefebvre, Strategy Research Assistant at the Access to Medicine Foundation, will speak at the Student Conference for Corporate Responsibility taking place at Yale University, New Haven, USA. 

Date

13 April 2019

Thomas will join a panel discussion titled 'Hot Topics in Investor Activism', sharing key findings of the 2018 Access to Medicine Index and the Access to Medicine Foundation’s investor engagement programme. The aim of the panel discussion is to broaden students' understanding of financial activism related to specific issues, one of them being access to medicine. 

The Student Conference for Corporate Responsibility is the first ever student-run conference on shareholder engagement, bridging the gap between finance and social activism, building a coalition of undergraduate investment funds and future finance professionals for the purpose of corporate responsibility. The conference is co-hosted by the Dwight Hall SRI Fund and the Intentional Endowments Network.

Investor engagement at the Access to Medicine Foundation
89 institutional investors, collectively managing assets in excess of $11 trillion, have already committed to using the Access to Medicine Index in their investment analyses and engagements with companies, by signing the Index investor statement. The Sustainability Accounting Standard Board (SASB) makes explicit reference to the framework of the Access to Medicine Index in the recently published SASB Standard for the Biotechnology & Pharmaceuticals industry. 

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved